Literature DB >> 19906422

Effects of VEGF temporal and spatial presentation on angiogenesis.

Eduardo A Silva1, David J Mooney.   

Abstract

Therapeutic angiogenesis relies on the delivery of angiogenic factors capable of reversing tissue ischemia. Polymeric materials that can provide spatial and temporal over vascular endothelial growth factor (VEGF) presentation provide clear benefit, but the influence of VEGF dose, temporal, and spatial presentation on the resultant angiogenic process are largely unknown. The influence of the temporal profile of VEGF concentration, dose, and the impact of VEGF spatial distribution on angiogenesis in in vitro models of angiogenesis and ischemic murine limbs was analyzed in this study. Importantly, a profile consisting of a high VEGF concentration initially, followed by a decreasing concentration over time was found to yield optimal angiogenic sprouting. A total VEGF dose 0.1 microg/g, when delivered with kinetics found to be optimal in vitro, provided a favorable therapeutic dose in murine hindlimb ischemia model, and distributing this VEGF dose in two spatial locations induces a higher level of vascularization and perfusion than a single location. These findings suggest that material systems capable of controlling and regulating the temporal and spatial presentation of VEGF maybe useful to achieve a robust and potent therapeutic angiogenic effect in vivo. (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19906422      PMCID: PMC2813952          DOI: 10.1016/j.biomaterials.2009.10.052

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  30 in total

Review 1.  Therapeutic angiogenesis in cardiovascular disease.

Authors:  Michael Simons; J Anthony Ware
Journal:  Nat Rev Drug Discov       Date:  2003-11       Impact factor: 84.694

2.  Angiogenic sprouting and capillary lumen formation modeled by human umbilical vein endothelial cells (HUVEC) in fibrin gels: the role of fibroblasts and Angiopoietin-1.

Authors:  Martin N Nakatsu; Richard C A Sainson; Jason N Aoto; Kevin L Taylor; Mark Aitkenhead; Sofía Pérez-del-Pulgar; Philip M Carpenter; Christopher C W Hughes
Journal:  Microvasc Res       Date:  2003-09       Impact factor: 3.514

3.  Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis.

Authors:  Clare R Ozawa; Andrea Banfi; Nicole L Glazer; Gavin Thurston; Matthew L Springer; Peggy E Kraft; Donald M McDonald; Helen M Blau
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

4.  Polymeric system for dual growth factor delivery.

Authors:  T P Richardson; M C Peters; A B Ennett; D J Mooney
Journal:  Nat Biotechnol       Date:  2001-11       Impact factor: 54.908

5.  Controlling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distribution.

Authors:  Tanyarut Boontheekul; Hyun-Joon Kong; David J Mooney
Journal:  Biomaterials       Date:  2005-05       Impact factor: 12.479

6.  Degradation of partially oxidized alginate and its potential application for tissue engineering.

Authors:  K H Bouhadir; K Y Lee; E Alsberg; K L Damm; K W Anderson; D J Mooney
Journal:  Biotechnol Prog       Date:  2001 Sep-Oct

7.  Isolation and culture of microvascular endothelial cells from the primate corpus luteum.

Authors:  L K Christenson; R L Stouffer
Journal:  Biol Reprod       Date:  1996-12       Impact factor: 4.285

8.  Local and sustained vascular endothelial growth factor delivery for angiogenesis using an injectable system.

Authors:  Jangwook Lee; Kuen Yong Lee
Journal:  Pharm Res       Date:  2009-04-21       Impact factor: 4.200

9.  VEGF(121) and VEGF(165) regulate blood vessel diameter through vascular endothelial growth factor receptor 2 in an in vitro angiogenesis model.

Authors:  Martin N Nakatsu; Richard C A Sainson; Sofía Pérez-del-Pulgar; Jason N Aoto; Mark Aitkenhead; Kevin L Taylor; Philip M Carpenter; Christopher C W Hughes
Journal:  Lab Invest       Date:  2003-12       Impact factor: 5.662

10.  VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia.

Authors:  Holger Gerhardt; Matthew Golding; Marcus Fruttiger; Christiana Ruhrberg; Andrea Lundkvist; Alexandra Abramsson; Michael Jeltsch; Christopher Mitchell; Kari Alitalo; David Shima; Christer Betsholtz
Journal:  J Cell Biol       Date:  2003-06-16       Impact factor: 10.539

View more
  70 in total

1.  Guided bone regeneration using injectable vascular endothelial growth factor delivery gel.

Authors:  Darnell Kaigler; Eduardo A Silva; David J Mooney
Journal:  J Periodontol       Date:  2012-06-05       Impact factor: 6.993

2.  Alginate: properties and biomedical applications.

Authors:  Kuen Yong Lee; David J Mooney
Journal:  Prog Polym Sci       Date:  2012-01       Impact factor: 29.190

3.  Alginate Sulfates Mitigate Binding Kinetics of Proangiogenic Growth Factors with Receptors toward Revascularization.

Authors:  John Schmidt; Min Kyung Lee; Eunkyung Ko; Jae Hyun Jeong; Luisa A DiPietro; Hyunjoon Kong
Journal:  Mol Pharm       Date:  2016-02-29       Impact factor: 4.939

4.  Hyperactive FOXO1 results in lack of tip stalk identity and deficient microvascular regeneration during kidney injury.

Authors:  Lan T H Dang; Takahide Aburatani; Graham A Marsh; Bryce G Johnson; Stella Alimperti; Christine J Yoon; Angela Huang; Suzanne Szak; Naoki Nakagawa; Ivan Gomez; Shuyu Ren; Sarah K Read; Chris Sparages; Alfred C Aplin; Roberto F Nicosia; Chris Chen; Giovanni Ligresti; Jeremy S Duffield
Journal:  Biomaterials       Date:  2017-07-07       Impact factor: 12.479

Review 5.  Macroscale delivery systems for molecular and cellular payloads.

Authors:  Cathal J Kearney; David J Mooney
Journal:  Nat Mater       Date:  2013-11       Impact factor: 43.841

6.  Designing hydrogels for controlled drug delivery.

Authors:  Jianyu Li; David J Mooney
Journal:  Nat Rev Mater       Date:  2016-10-18       Impact factor: 66.308

7.  Scaffold-mediated BMP-2 minicircle DNA delivery accelerated bone repair in a mouse critical-size calvarial defect model.

Authors:  Michael Keeney; Michael T Chung; Elizabeth R Zielins; Kevin J Paik; Adrian McArdle; Shane D Morrison; Ryan C Ransom; Namrata Barbhaiya; David Atashroo; Gunilla Jacobson; Richard N Zare; Michael T Longaker; Derrick C Wan; Fan Yang
Journal:  J Biomed Mater Res A       Date:  2016-06-03       Impact factor: 4.396

8.  Sustained delivery of VEGF maintains innervation and promotes reperfusion in ischemic skeletal muscles via NGF/GDNF signaling.

Authors:  Dmitry Shvartsman; Hannah Storrie-White; Kangwon Lee; Cathal Kearney; Yevgeny Brudno; Nhi Ho; Christine Cezar; Corey McCann; Erin Anderson; John Koullias; Juan Carlos Tapia; Herman Vandenburgh; Jeff W Lichtman; David J Mooney
Journal:  Mol Ther       Date:  2014-04-28       Impact factor: 11.454

9.  Minimally invasive approach to the repair of injured skeletal muscle with a shape-memory scaffold.

Authors:  Lin Wang; Lan Cao; Janet Shansky; Zheng Wang; David Mooney; Herman Vandenburgh
Journal:  Mol Ther       Date:  2014-04-28       Impact factor: 11.454

10.  Microgels produced using microfluidic on-chip polymer blending for controlled released of VEGF encoding lentivectors.

Authors:  Justin L Madrigal; Shonit N Sharma; Kevin T Campbell; Roberta S Stilhano; Rik Gijsbers; Eduardo A Silva
Journal:  Acta Biomater       Date:  2018-02-02       Impact factor: 8.947

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.